Blog

Amer Zeidan: Amazing work by our Yale Hematology Oncology Fellows at EHA2024

Photo taken from Amer Zeidan/X

Jun 15, 2024, 09:46

Amer Zeidan: Amazing work by our Yale Hematology Oncology Fellows at EHA2024

Amer Zeidan shared a post on X:

“Amazing work by our Yale Hematology Oncology Fellows presenting 6 posters at European Hematology Association
EHA2024 meeting in Madrid Dr. Jessica Stemple, Dr. Theodore Getz, Dr. Tariq Kewan & incoming faculty Dr. Jan Bewersdorf Yale Cancer Center, Yale Hematology, Yale School of Medicine, Yale University using International Consortium for MDS (icMDS) database.”

Source: Amer Zeidan/X

Amer Zeidan is an Associate Professor of Medicine (Hematology) at Yale University. He is also the medical director of Hematology Early Therapeutics Research, the leader of the Myeloid Malignancies DART (Disease Aligned Research Team), and the director of Continuing Medical Education (CME) at the Hematology division and chairs the Protocol Review Committee (PRC) at Yale Cancer Center. Dr. Zeidan is a well-known leukemia researcher with a special focus on targeted therapies and immunotherapy for myeloid malignancies, and a social media influencer in the field of blood cancer.

Amer Zeidan cancer EHA2024 European Hematology Association hematology posters icMDS database MDS research OncoDaily Oncology Yale Cancer Center Yale Hematology Oncology Yale School of Medicine

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Agenus and Tanner Pharma Partner to Expand Global Access to BOT/BAL

Special Coverage